Skip to main content
Premium Trial:

Request an Annual Quote

Virginia Tech Lands NIH Funds for Systems Biology

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) –Virginia Tech researchers will use a $2.1 million federal grant to develop systems biology approaches to studying cellular responses, the university said Wednesday.

The National Institutes of Health grant will fund interdisciplinary and collaborative approaches to studying cell cycle control in budding yeast.

Virginia Tech Associate Professor of Computer Science T.M. Murali said the researchers will use both 'top-down' and 'bottom-up' approaches to studying complex cellular systems.

"The first, top-down approach automatically analyzes large-scale datasets for correlations between genes and proteins. However, it is often difficult to design experiments from these results," Murali said.

"The second, bottom-up approach painstakingly crafts detailed models that can be simulated computationally. Although such simulations can suggest wet lab experiments, developing the models is a manual process that can take many years," he said. "Our project will meld the strengths of these two approaches into a single framework, thereby allowing efficient and automated data-driven analysis to augment models that can be simulated."

The researchers will develop a framework for generating hypotheses from top-down models, testing hypotheses by integrating them into bottom-up models, and validating them using experiments.

While the research will focus on yeast, Murali said that the methods they develop should be "relevant to the study of any complex cellular system, including the development of cancer and the spread of infectious diseases.

"If we are successful, our project will result in significant advances in computationally driven experimental biology," he said.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.